| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Ischemia | 42 | 2022 | 179 | 7.180 |
Why?
|
| Ischemic Preconditioning | 21 | 2016 | 48 | 3.450 |
Why?
|
| Nerve Tissue Proteins | 16 | 2013 | 338 | 2.790 |
Why?
|
| Stroke | 16 | 2020 | 274 | 2.400 |
Why?
|
| Brain | 27 | 2020 | 1268 | 2.240 |
Why?
|
| Neurons | 41 | 2020 | 1130 | 2.230 |
Why?
|
| Sodium Channels | 13 | 2011 | 63 | 2.030 |
Why?
|
| Membrane Proteins | 13 | 2011 | 486 | 1.690 |
Why?
|
| Hippocampus | 23 | 2020 | 546 | 1.410 |
Why?
|
| Animals | 88 | 2023 | 14307 | 1.230 |
Why?
|
| Neuroprotective Agents | 15 | 2018 | 231 | 1.030 |
Why?
|
| Nerve Degeneration | 7 | 2011 | 101 | 1.030 |
Why?
|
| Epilepsy | 9 | 2012 | 41 | 1.000 |
Why?
|
| Mice | 54 | 2023 | 5668 | 1.000 |
Why?
|
| Seizures | 10 | 2012 | 67 | 0.970 |
Why?
|
| Reperfusion Injury | 3 | 2018 | 53 | 0.930 |
Why?
|
| Acidosis | 10 | 2020 | 49 | 0.890 |
Why?
|
| DNA Repair | 3 | 2018 | 181 | 0.870 |
Why?
|
| Rats | 33 | 2022 | 3261 | 0.850 |
Why?
|
| Infarction, Middle Cerebral Artery | 15 | 2020 | 76 | 0.840 |
Why?
|
| Protons | 2 | 2022 | 80 | 0.840 |
Why?
|
| DNA, Mitochondrial | 2 | 2018 | 165 | 0.830 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2018 | 20 | 0.800 |
Why?
|
| Calcium | 13 | 2020 | 445 | 0.780 |
Why?
|
| Gene Expression Regulation | 9 | 2011 | 968 | 0.760 |
Why?
|
| Ischemia | 4 | 2022 | 45 | 0.750 |
Why?
|
| Cells, Cultured | 24 | 2016 | 1442 | 0.680 |
Why?
|
| Gene Expression | 3 | 2015 | 639 | 0.650 |
Why?
|
| Brain Injuries | 4 | 2017 | 104 | 0.620 |
Why?
|
| Ubiquitin | 3 | 2008 | 76 | 0.590 |
Why?
|
| Disease Models, Animal | 21 | 2018 | 1300 | 0.580 |
Why?
|
| Cerebral Cortex | 12 | 2016 | 274 | 0.560 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2008 | 109 | 0.560 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2004 | 40 | 0.540 |
Why?
|
| Genomics | 3 | 2017 | 201 | 0.530 |
Why?
|
| Apoptosis Regulatory Proteins | 7 | 2011 | 146 | 0.500 |
Why?
|
| Male | 51 | 2020 | 18870 | 0.500 |
Why?
|
| Epigenesis, Genetic | 2 | 2015 | 198 | 0.490 |
Why?
|
| Mice, Inbred C57BL | 21 | 2016 | 1530 | 0.490 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2007 | 180 | 0.480 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2016 | 1534 | 0.480 |
Why?
|
| Hydrogen-Ion Concentration | 10 | 2022 | 342 | 0.480 |
Why?
|
| Cell Death | 13 | 2012 | 260 | 0.470 |
Why?
|
| Globins | 1 | 2013 | 9 | 0.470 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2011 | 229 | 0.460 |
Why?
|
| Epilepsy, Temporal Lobe | 4 | 2012 | 16 | 0.450 |
Why?
|
| Neurogenesis | 1 | 2013 | 55 | 0.450 |
Why?
|
| Caspases | 6 | 2006 | 132 | 0.420 |
Why?
|
| DNA Glycosylases | 3 | 2018 | 16 | 0.420 |
Why?
|
| Apoptosis | 10 | 2008 | 1317 | 0.410 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2022 | 69 | 0.390 |
Why?
|
| Phenotype | 3 | 2009 | 650 | 0.380 |
Why?
|
| Electroencephalography | 8 | 2016 | 108 | 0.380 |
Why?
|
| Membrane Potentials | 7 | 2016 | 213 | 0.370 |
Why?
|
| Signal Transduction | 10 | 2022 | 1802 | 0.360 |
Why?
|
| Cytoprotection | 2 | 2008 | 32 | 0.360 |
Why?
|
| Humans | 34 | 2020 | 34853 | 0.350 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 101 | 0.350 |
Why?
|
| Mice, Knockout | 12 | 2020 | 897 | 0.350 |
Why?
|
| Adenosine Kinase | 6 | 2008 | 9 | 0.350 |
Why?
|
| Status Epilepticus | 4 | 2011 | 11 | 0.350 |
Why?
|
| Glutamic Acid | 2 | 2011 | 115 | 0.330 |
Why?
|
| Cerebrovascular Circulation | 3 | 2007 | 71 | 0.330 |
Why?
|
| Lipopolysaccharides | 5 | 2011 | 200 | 0.330 |
Why?
|
| Cricetulus | 7 | 2023 | 74 | 0.330 |
Why?
|
| CHO Cells | 7 | 2023 | 107 | 0.320 |
Why?
|
| Vitamin A | 1 | 2008 | 87 | 0.320 |
Why?
|
| Brain Infarction | 2 | 2012 | 20 | 0.320 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2012 | 325 | 0.320 |
Why?
|
| Cricetinae | 7 | 2023 | 217 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2005 | 139 | 0.320 |
Why?
|
| Membrane Glycoproteins | 3 | 2012 | 197 | 0.320 |
Why?
|
| Cell Membrane | 1 | 2010 | 360 | 0.310 |
Why?
|
| Calcineurin | 1 | 2007 | 21 | 0.310 |
Why?
|
| Kainic Acid | 12 | 2012 | 47 | 0.310 |
Why?
|
| Carrier Proteins | 7 | 2008 | 287 | 0.300 |
Why?
|
| Stem Cells | 1 | 2008 | 132 | 0.300 |
Why?
|
| MicroRNAs | 4 | 2012 | 386 | 0.290 |
Why?
|
| Synapses | 1 | 2008 | 173 | 0.290 |
Why?
|
| Neurodegenerative Diseases | 1 | 2007 | 119 | 0.280 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2022 | 131 | 0.280 |
Why?
|
| Reperfusion | 3 | 2018 | 15 | 0.270 |
Why?
|
| Proprotein Convertase 2 | 2 | 2020 | 16 | 0.270 |
Why?
|
| Neuropeptides | 2 | 2009 | 57 | 0.260 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 50 | 0.260 |
Why?
|
| Carboxypeptidase H | 1 | 2004 | 5 | 0.250 |
Why?
|
| Hibernation | 1 | 2003 | 7 | 0.240 |
Why?
|
| In Situ Nick-End Labeling | 6 | 2006 | 126 | 0.240 |
Why?
|
| N-Methylaspartate | 2 | 2022 | 55 | 0.240 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2003 | 2 | 0.240 |
Why?
|
| Amiloride | 3 | 2016 | 16 | 0.240 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2023 | 3 | 0.230 |
Why?
|
| Ischemic Attack, Transient | 1 | 2003 | 20 | 0.230 |
Why?
|
| Proteins | 5 | 2011 | 352 | 0.220 |
Why?
|
| Immunohistochemistry | 6 | 2008 | 859 | 0.220 |
Why?
|
| Time Factors | 9 | 2011 | 1681 | 0.210 |
Why?
|
| Proteomics | 3 | 2014 | 302 | 0.210 |
Why?
|
| Blotting, Western | 8 | 2012 | 834 | 0.200 |
Why?
|
| Mammals | 1 | 2022 | 96 | 0.200 |
Why?
|
| Proteome | 2 | 2014 | 132 | 0.200 |
Why?
|
| Thrombolytic Therapy | 2 | 2018 | 17 | 0.200 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2020 | 75 | 0.200 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2007 | 160 | 0.200 |
Why?
|
| Tyrosine 3-Monooxygenase | 4 | 2004 | 72 | 0.190 |
Why?
|
| Dynamins | 1 | 2020 | 15 | 0.190 |
Why?
|
| Maze Learning | 1 | 2020 | 100 | 0.180 |
Why?
|
| Phosphorylation | 5 | 2020 | 878 | 0.180 |
Why?
|
| Extracellular Fluid | 2 | 2011 | 13 | 0.180 |
Why?
|
| In Situ Hybridization | 4 | 2012 | 125 | 0.170 |
Why?
|
| Analysis of Variance | 6 | 2012 | 528 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2016 | 984 | 0.160 |
Why?
|
| Patch-Clamp Techniques | 5 | 2016 | 214 | 0.160 |
Why?
|
| Mitochondria | 5 | 2020 | 454 | 0.160 |
Why?
|
| Post-Concussion Syndrome | 1 | 2017 | 4 | 0.160 |
Why?
|
| Nuclear Proteins | 6 | 2010 | 287 | 0.160 |
Why?
|
| Protein Kinases | 3 | 2007 | 91 | 0.150 |
Why?
|
| Female | 14 | 2020 | 19873 | 0.150 |
Why?
|
| Embryo, Mammalian | 3 | 2016 | 152 | 0.150 |
Why?
|
| Down-Regulation | 5 | 2011 | 420 | 0.150 |
Why?
|
| Adenosine | 5 | 2007 | 54 | 0.150 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 3 | 2006 | 21 | 0.150 |
Why?
|
| Amygdala | 4 | 2011 | 110 | 0.140 |
Why?
|
| Enzyme Inhibitors | 4 | 2008 | 396 | 0.140 |
Why?
|
| Histone Code | 1 | 2015 | 12 | 0.140 |
Why?
|
| Up-Regulation | 8 | 2012 | 490 | 0.140 |
Why?
|
| RNA | 1 | 2017 | 234 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2008 | 184 | 0.130 |
Why?
|
| Sleep | 1 | 2016 | 122 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2008 | 298 | 0.130 |
Why?
|
| Zinc | 2 | 2007 | 114 | 0.130 |
Why?
|
| Ion Channel Gating | 1 | 2014 | 81 | 0.120 |
Why?
|
| Sensory Receptor Cells | 1 | 2014 | 31 | 0.120 |
Why?
|
| Olfactory Bulb | 1 | 2014 | 48 | 0.120 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2003 | 32 | 0.120 |
Why?
|
| Microarray Analysis | 3 | 2009 | 61 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2013 | 23 | 0.120 |
Why?
|
| Sex Factors | 2 | 2013 | 859 | 0.110 |
Why?
|
| Adaptation, Physiological | 2 | 2012 | 106 | 0.110 |
Why?
|
| Activities of Daily Living | 1 | 2013 | 104 | 0.110 |
Why?
|
| Calcium Channels | 2 | 2011 | 72 | 0.110 |
Why?
|
| Antigens, CD | 2 | 2003 | 116 | 0.110 |
Why?
|
| Glucose | 3 | 2011 | 217 | 0.110 |
Why?
|
| Animals, Newborn | 3 | 2009 | 323 | 0.110 |
Why?
|
| DNA Methylation | 1 | 2015 | 301 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2020 | 605 | 0.110 |
Why?
|
| Sclerosis | 1 | 2012 | 6 | 0.110 |
Why?
|
| Killifishes | 1 | 2012 | 2 | 0.110 |
Why?
|
| Tetrazolium Salts | 2 | 2011 | 36 | 0.110 |
Why?
|
| Ribonuclease III | 1 | 2012 | 10 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 11 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 224 | 0.110 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2012 | 1 | 0.110 |
Why?
|
| Aminoquinolines | 1 | 2012 | 14 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2011 | 97 | 0.110 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2012 | 8 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2011 | 94 | 0.110 |
Why?
|
| Embryo, Nonmammalian | 1 | 2012 | 57 | 0.110 |
Why?
|
| 14-3-3 Proteins | 4 | 2004 | 19 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2003 | 423 | 0.100 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 600 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2013 | 233 | 0.100 |
Why?
|
| Interferon Regulatory Factors | 1 | 2011 | 15 | 0.100 |
Why?
|
| Imidazoles | 1 | 2012 | 124 | 0.100 |
Why?
|
| Lidocaine | 1 | 2011 | 15 | 0.100 |
Why?
|
| Toll-Like Receptors | 1 | 2011 | 47 | 0.100 |
Why?
|
| Protein Transport | 2 | 2010 | 286 | 0.100 |
Why?
|
| Ubiquitination | 1 | 2011 | 54 | 0.100 |
Why?
|
| Bromodeoxyuridine | 2 | 2008 | 22 | 0.100 |
Why?
|
| RNA, Messenger | 5 | 2009 | 1152 | 0.100 |
Why?
|
| TRPM Cation Channels | 1 | 2011 | 35 | 0.100 |
Why?
|
| Osteopontin | 2 | 2008 | 35 | 0.100 |
Why?
|
| Spermine | 1 | 2011 | 64 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 69 | 0.100 |
Why?
|
| Genes, Suppressor | 1 | 2009 | 3 | 0.090 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2009 | 6 | 0.090 |
Why?
|
| Medication Errors | 1 | 2009 | 6 | 0.090 |
Why?
|
| Cardiology Service, Hospital | 1 | 2009 | 4 | 0.090 |
Why?
|
| Genes, Regulator | 1 | 2009 | 25 | 0.090 |
Why?
|
| Documentation | 1 | 2009 | 15 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 181 | 0.090 |
Why?
|
| Electric Conductivity | 2 | 2007 | 47 | 0.090 |
Why?
|
| Propidium | 2 | 2007 | 18 | 0.090 |
Why?
|
| Patient Admission | 1 | 2009 | 40 | 0.090 |
Why?
|
| Drug Prescriptions | 1 | 2009 | 42 | 0.090 |
Why?
|
| Calcium Signaling | 2 | 2014 | 95 | 0.090 |
Why?
|
| Receptors, Glutamate | 2 | 2011 | 26 | 0.090 |
Why?
|
| Caspase 7 | 3 | 2007 | 16 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2011 | 252 | 0.090 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2009 | 12 | 0.090 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 1490 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2011 | 92 | 0.090 |
Why?
|
| Cell Nucleus | 3 | 2006 | 351 | 0.090 |
Why?
|
| Dynorphins | 1 | 2009 | 14 | 0.090 |
Why?
|
| Synaptic Transmission | 1 | 2010 | 141 | 0.090 |
Why?
|
| Models, Neurological | 2 | 2007 | 123 | 0.090 |
Why?
|
| Diazepam | 3 | 2004 | 10 | 0.090 |
Why?
|
| Indicators and Reagents | 1 | 2008 | 57 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2013 | 1349 | 0.080 |
Why?
|
| Convulsants | 2 | 2012 | 5 | 0.080 |
Why?
|
| Memory | 1 | 2010 | 165 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 120 | 0.080 |
Why?
|
| Simplexvirus | 1 | 2008 | 10 | 0.080 |
Why?
|
| Epilepsies, Partial | 1 | 2008 | 3 | 0.080 |
Why?
|
| Stereoisomerism | 1 | 2008 | 162 | 0.080 |
Why?
|
| Ki-67 Antigen | 1 | 2008 | 32 | 0.080 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2008 | 9 | 0.080 |
Why?
|
| Carbocyanines | 1 | 2008 | 14 | 0.080 |
Why?
|
| Insulin | 1 | 2010 | 224 | 0.080 |
Why?
|
| Biomimetic Materials | 1 | 2008 | 23 | 0.080 |
Why?
|
| Vitamins | 1 | 2008 | 91 | 0.080 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2007 | 6 | 0.080 |
Why?
|
| Middle Cerebral Artery | 1 | 2007 | 16 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 64 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2010 | 226 | 0.080 |
Why?
|
| Lentivirus | 1 | 2007 | 20 | 0.080 |
Why?
|
| Kindling, Neurologic | 1 | 2007 | 2 | 0.080 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2007 | 7 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2008 | 1124 | 0.080 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2007 | 33 | 0.080 |
Why?
|
| Middle Aged | 6 | 2017 | 9642 | 0.080 |
Why?
|
| Electrophysiology | 4 | 2010 | 130 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2007 | 54 | 0.070 |
Why?
|
| Dizocilpine Maleate | 1 | 2007 | 45 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2012 | 200 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 117 | 0.070 |
Why?
|
| Endodeoxyribonucleases | 2 | 2006 | 29 | 0.070 |
Why?
|
| Pyramidal Cells | 2 | 2006 | 60 | 0.070 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 49 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 57 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2009 | 298 | 0.070 |
Why?
|
| Stem Cell Transplantation | 1 | 2006 | 31 | 0.070 |
Why?
|
| Electric Stimulation | 3 | 2016 | 177 | 0.070 |
Why?
|
| Astrocytes | 2 | 2008 | 203 | 0.070 |
Why?
|
| Ions | 1 | 2006 | 61 | 0.070 |
Why?
|
| RNA Interference | 1 | 2007 | 225 | 0.070 |
Why?
|
| Leupeptins | 1 | 2006 | 11 | 0.070 |
Why?
|
| Deoxyribonucleases | 1 | 2006 | 25 | 0.070 |
Why?
|
| Butadienes | 1 | 2006 | 30 | 0.070 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2006 | 38 | 0.070 |
Why?
|
| Base Sequence | 2 | 2010 | 932 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 54 | 0.070 |
Why?
|
| Caspase 6 | 2 | 2002 | 4 | 0.070 |
Why?
|
| Lamins | 2 | 2002 | 5 | 0.070 |
Why?
|
| Neuronal Plasticity | 1 | 2007 | 102 | 0.070 |
Why?
|
| Lamin Type A | 2 | 2002 | 13 | 0.070 |
Why?
|
| Staurosporine | 2 | 2002 | 35 | 0.070 |
Why?
|
| Nitriles | 1 | 2006 | 66 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2006 | 170 | 0.070 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 10 | 0.070 |
Why?
|
| Adult | 6 | 2017 | 11034 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 52 | 0.060 |
Why?
|
| Organ Culture Techniques | 2 | 2020 | 99 | 0.060 |
Why?
|
| Glioma | 2 | 2002 | 76 | 0.060 |
Why?
|
| Sodium Channel Blockers | 1 | 2004 | 16 | 0.060 |
Why?
|
| COS Cells | 1 | 2004 | 62 | 0.060 |
Why?
|
| Endotoxins | 1 | 2004 | 18 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 56 | 0.060 |
Why?
|
| Temporal Lobe | 1 | 2004 | 22 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 480 | 0.060 |
Why?
|
| Potassium Channels | 1 | 2004 | 73 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2004 | 59 | 0.060 |
Why?
|
| Protein Binding | 4 | 2011 | 913 | 0.060 |
Why?
|
| Bleeding Time | 1 | 2003 | 5 | 0.060 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2003 | 3 | 0.060 |
Why?
|
| Biophysics | 2 | 2016 | 36 | 0.060 |
Why?
|
| Cell Survival | 2 | 2004 | 818 | 0.060 |
Why?
|
| Cycloheximide | 3 | 2009 | 30 | 0.060 |
Why?
|
| Sequence Homology | 1 | 2003 | 34 | 0.060 |
Why?
|
| Drug Design | 1 | 2004 | 154 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2003 | 20 | 0.060 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2003 | 14 | 0.060 |
Why?
|
| DNA Damage | 1 | 2006 | 341 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2017 | 628 | 0.060 |
Why?
|
| Cell Count | 1 | 2003 | 129 | 0.060 |
Why?
|
| Dendrites | 1 | 2003 | 52 | 0.060 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2003 | 6 | 0.060 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 2003 | 4 | 0.060 |
Why?
|
| DNA Ligases | 1 | 2003 | 11 | 0.060 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2003 | 18 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2003 | 41 | 0.060 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 74 | 0.060 |
Why?
|
| DNA | 1 | 2006 | 549 | 0.060 |
Why?
|
| Alanine | 2 | 2014 | 28 | 0.060 |
Why?
|
| GABA Agonists | 1 | 2002 | 21 | 0.060 |
Why?
|
| Enzyme Induction | 1 | 2002 | 48 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2002 | 72 | 0.050 |
Why?
|
| Transfection | 2 | 2016 | 496 | 0.050 |
Why?
|
| Microinjections | 1 | 2002 | 55 | 0.050 |
Why?
|
| Glycine | 1 | 2022 | 44 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2008 | 1149 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 210 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2002 | 33 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2002 | 33 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 240 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 2017 | 175 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 430 | 0.050 |
Why?
|
| Actins | 1 | 2022 | 142 | 0.050 |
Why?
|
| Neuroglia | 1 | 2002 | 117 | 0.050 |
Why?
|
| Oligonucleotides | 2 | 2011 | 48 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 455 | 0.050 |
Why?
|
| Hela Cells | 1 | 2002 | 344 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2008 | 608 | 0.050 |
Why?
|
| Caspase 8 | 3 | 2006 | 31 | 0.050 |
Why?
|
| Functional Laterality | 3 | 2006 | 75 | 0.050 |
Why?
|
| Mutation | 3 | 2011 | 1023 | 0.050 |
Why?
|
| Protein Phosphatase 2 | 1 | 2020 | 22 | 0.050 |
Why?
|
| Aged | 4 | 2013 | 6448 | 0.050 |
Why?
|
| Superoxides | 1 | 2020 | 51 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2011 | 59 | 0.050 |
Why?
|
| Aging | 1 | 2004 | 639 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2020 | 110 | 0.050 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2011 | 47 | 0.050 |
Why?
|
| Models, Animal | 2 | 2012 | 131 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2004 | 653 | 0.040 |
Why?
|
| Homeostasis | 1 | 2020 | 172 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 391 | 0.040 |
Why?
|
| Military Medicine | 1 | 2017 | 9 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2013 | 1353 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 2009 | 20 | 0.040 |
Why?
|
| Military Personnel | 1 | 2017 | 67 | 0.040 |
Why?
|
| Propionates | 1 | 2016 | 25 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 60 | 0.040 |
Why?
|
| Caspase 9 | 2 | 2007 | 27 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 81 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 555 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 484 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2016 | 156 | 0.030 |
Why?
|
| DNA Fragmentation | 2 | 2007 | 91 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 2333 | 0.030 |
Why?
|
| Genetic Vectors | 2 | 2007 | 154 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 2 | 2006 | 13 | 0.030 |
Why?
|
| Subcellular Fractions | 2 | 2006 | 72 | 0.030 |
Why?
|
| Antibodies | 2 | 2007 | 135 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2006 | 185 | 0.030 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 2 | 2004 | 8 | 0.030 |
Why?
|
| Alabama | 1 | 2013 | 46 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 52 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2014 | 100 | 0.030 |
Why?
|
| Caspase 3 | 2 | 2006 | 194 | 0.030 |
Why?
|
| Independent Living | 1 | 2013 | 31 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 188 | 0.030 |
Why?
|
| Adolescent | 1 | 2004 | 5035 | 0.030 |
Why?
|
| Anticonvulsants | 2 | 2004 | 34 | 0.030 |
Why?
|
| Models, Biological | 2 | 2006 | 642 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2005 | 245 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 255 | 0.030 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2012 | 1 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 19 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 751 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2012 | 42 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 2011 | 11 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 485 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2017 | 1961 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2011 | 39 | 0.030 |
Why?
|
| Picrotoxin | 1 | 2011 | 10 | 0.030 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2011 | 4 | 0.030 |
Why?
|
| Putrescine | 1 | 2011 | 25 | 0.020 |
Why?
|
| GABA Antagonists | 1 | 2011 | 25 | 0.020 |
Why?
|
| Valine | 1 | 2011 | 31 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 89 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 392 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2011 | 137 | 0.020 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2010 | 2 | 0.020 |
Why?
|
| Carcinogens | 1 | 2011 | 117 | 0.020 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 2010 | 6 | 0.020 |
Why?
|
| Rodentia | 1 | 2010 | 41 | 0.020 |
Why?
|
| Medical Records | 1 | 2009 | 37 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 20 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 275 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2009 | 33 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 1003 | 0.020 |
Why?
|
| Polypharmacy | 1 | 2009 | 27 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2009 | 67 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 233 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2009 | 92 | 0.020 |
Why?
|
| Hyperthermia, Induced | 1 | 2009 | 17 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 1425 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2009 | 97 | 0.020 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2008 | 21 | 0.020 |
Why?
|
| Ion Channels | 1 | 2008 | 69 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 147 | 0.020 |
Why?
|
| Thrombin | 1 | 2008 | 24 | 0.020 |
Why?
|
| Reactive Nitrogen Species | 1 | 2008 | 10 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 2008 | 77 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 152 | 0.020 |
Why?
|
| Integrins | 1 | 2008 | 49 | 0.020 |
Why?
|
| Long-Term Potentiation | 1 | 2008 | 99 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2008 | 52 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2007 | 19 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2007 | 45 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 78 | 0.020 |
Why?
|
| Shear Strength | 1 | 2007 | 23 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2007 | 14 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2007 | 51 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 70 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2007 | 31 | 0.020 |
Why?
|
| Sodium Bicarbonate | 1 | 2006 | 8 | 0.020 |
Why?
|
| Spider Venoms | 1 | 2006 | 7 | 0.020 |
Why?
|
| Cerebral Infarction | 1 | 2006 | 17 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2007 | 123 | 0.020 |
Why?
|
| Solubility | 1 | 2007 | 115 | 0.020 |
Why?
|
| Cerebral Ventricles | 1 | 2006 | 23 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2007 | 37 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2006 | 19 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2007 | 202 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 110 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 317 | 0.020 |
Why?
|
| Tubercidin | 1 | 2006 | 4 | 0.020 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2006 | 4 | 0.020 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2006 | 7 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2006 | 28 | 0.020 |
Why?
|
| DNA Polymerase beta | 1 | 2006 | 13 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2006 | 66 | 0.020 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2006 | 16 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 2007 | 99 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 2561 | 0.020 |
Why?
|
| Alleles | 1 | 2006 | 284 | 0.020 |
Why?
|
| Prognosis | 1 | 2008 | 707 | 0.020 |
Why?
|
| Peptides | 1 | 2008 | 308 | 0.020 |
Why?
|
| Indoles | 1 | 2006 | 154 | 0.020 |
Why?
|
| Lateral Ventricles | 1 | 2004 | 8 | 0.020 |
Why?
|
| Apoptotic Protease-Activating Factor 1 | 1 | 2004 | 2 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2004 | 26 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2004 | 39 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2005 | 97 | 0.020 |
Why?
|
| Lorazepam | 1 | 2004 | 1 | 0.020 |
Why?
|
| Genes, bcl-2 | 1 | 2004 | 6 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2004 | 53 | 0.020 |
Why?
|
| bcl-Associated Death Protein | 1 | 2004 | 6 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2004 | 228 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2004 | 52 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2004 | 85 | 0.020 |
Why?
|
| Leukocytes | 1 | 2004 | 68 | 0.020 |
Why?
|
| Microsomes | 1 | 2004 | 52 | 0.020 |
Why?
|
| Denervation | 1 | 2004 | 26 | 0.020 |
Why?
|
| Lysine | 1 | 2004 | 104 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2004 | 72 | 0.020 |
Why?
|
| Casein Kinases | 1 | 2003 | 1 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 310 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2003 | 13 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 135 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2004 | 74 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2004 | 39 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2003 | 16 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2003 | 16 | 0.010 |
Why?
|
| Lipofuscin | 1 | 2003 | 4 | 0.010 |
Why?
|
| United States | 1 | 2013 | 3894 | 0.010 |
Why?
|
| Erythropoietin | 1 | 2003 | 37 | 0.010 |
Why?
|
| Inflammation | 1 | 2008 | 577 | 0.010 |
Why?
|
| Azo Compounds | 1 | 2003 | 18 | 0.010 |
Why?
|
| Quality Control | 1 | 2003 | 35 | 0.010 |
Why?
|
| Diuretics | 1 | 2003 | 49 | 0.010 |
Why?
|
| Cell Line | 1 | 2007 | 1289 | 0.010 |
Why?
|
| Naphthalenes | 1 | 2003 | 37 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2004 | 135 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2003 | 42 | 0.010 |
Why?
|
| Microglia | 1 | 2004 | 152 | 0.010 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2002 | 14 | 0.010 |
Why?
|
| Limbic System | 1 | 2002 | 25 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 200 | 0.010 |
Why?
|
| Monocytes | 1 | 2004 | 258 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 649 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2008 | 874 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2004 | 562 | 0.010 |
Why?
|
| Cell Movement | 1 | 2004 | 545 | 0.010 |
Why?
|
| Macrophages | 1 | 2004 | 431 | 0.010 |
Why?
|